Taysha Gene Therapies, Inc.

Website

NASDAQ: TSHA

A biotechnology company focused on developing gene therapies for neurological diseases.

CCI Score

-27.56

0.02% April 18

Latest Event

Taysha Gene Therapies 2023 Lobbying Expenditure

Taysha Gene Therapies, Inc. spent $20,000 on lobbying efforts in 2023, as detailed by OpenSecrets. The expenditure indicates the company's involvement in influencing policy through financial means.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: Maze Therapeutics

Nature Microbiology

CRISPR Therapeutics
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

ACCOMPLICE

Taysha Gene Therapies, Inc. is currently rated as an Accomplice.

-20 to -29 CCI Score

These companies profit from authoritarian practices through their business dealings. Although they may not be directly enforcing oppressive policies, their actions contribute to the economic and operational sustenance of authoritarian regimes.

Latest Events

DEC

31

2023

Taysha Gene Therapies 2023 Lobbying Expenditure
-8.78

Taysha Gene Therapies, Inc. spent $20,000 on lobbying efforts in 2023, as detailed by OpenSecrets. The expenditure indicates the company's involvement in influencing policy through financial means.
-10

Political Contributions and Lobbying Efforts

April 1

The company's use of $20,000 for lobbying in 2023 represents a clear instance of corporate engagement in the political process. Although the amount is relatively modest, it illustrates a reliance on financial influence to sway policy decisions, which can undermine democratic accountability and favor corporate interests.

Taysha Gene Therapies Lobbying Profile • OpenSecrets
MAR

31

2022

Substantial Workforce Reduction at Taysha Gene Therapies
-51.58

Taysha Gene Therapies cut roughly 35% of its headcount as a cost-saving measure aimed at extending its cash runway and narrowing focus to core gene therapy programs for GAN and Rett syndrome. The drastic downsizing, revealed in an SEC filing and reported by the Dallas Business Journal, raises concerns about the treatment and stability of its workforce.
-70

Labor Relations and Human Rights Practices

April 1

The decision to cut approximately 35% of Taysha's workforce undermines job security and worker rights, reflecting a troubling disregard for the welfare of employees. This drastic action, taken to extend the company's cash runway, signals a prioritization of short-term financial stability over long-term labor well‐being, which is particularly harmful from an anti-fascist and worker rights perspective.

Taysha Gene Therapies Cutting Roughly 35% of Its Headcount as It Narrows Focus
DEC

31

2021

Taysha Gene Therapies Lobbying Expenditure in 2021
-21.57

Taysha Gene Therapies spent $40,000 on lobbying activities in 2021, as reported by OpenSecrets. This expenditure highlights the company’s engagement in political lobbying, a practice often associated with efforts to influence public policy in favor of corporate interests.
-30

Political Contributions and Lobbying Efforts

April 1

The company’s allocation of $40,000 towards lobbying in 2021 is indicative of active political engagement aimed at influencing policy outcomes. From an anti-fascist perspective, such corporate lobbying can undermine democratic accountability by prioritizing narrow corporate interests over the broader public good.

Taysha Gene Therapies Lobbying Profile • OpenSecrets
NOV

01

2021

Taysha Cuts Workforce and Pauses R&D Programs
-28.29

Taysha Gene Therapies announced a strategic pause in several research and development programs and a 35% workforce reduction (about 60 employees) to extend its cash runway. The company is refocusing resources on its priority gene therapy programs for GAN and Rett syndrome, significantly impacting worker job security.
-40

Labor Relations and Human Rights Practices

April 1

The decision to cut 35% of the workforce undermines labor rights and job security, reflecting a prioritization of financial expediency over employee welfare. From a left-leaning anti-fascist perspective, such reductions contribute to the erosion of workers' power and are a negative signal in terms of corporate social responsibility.

Taysha Pauses Programs, Cuts Workforce to Extend Cash Runway